Q3FY17 Results : Cadila Healthcare
Bhagyashree Vivarekar / 31 Jan 2017
The company reported a PAT figure of Rs 274 crore which represents a sequential QoQ decline of 16.39 per cent and a YoY decline of 38.62 per cent.
Cadila Healthcare Ltd. reported its results for the quarter ended December 31,
The
Operating profit (EBIT) for the recently concluded quarter amounted to Rs 314.5 crore and the EBIT margin stood at 13.3 per cent.
The company reported a PAT figure of Rs 274 crore which represents a sequential QoQ decline of 16.39 per cent and a YoY decline of 38.62 per cent.
Cadila Healthcare limited is a global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products. The group's operations range from API to formulations, animal health
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.